Heart failure affects millions of people around the globe, and is expected to rise as populations age and diagnosis improves. To assess the impact of heart failure in the round, the CardioRenal and Metabolic disease (CaReMe) heart failure study was designed to estimate the prevalence, key unfavorable outcomes, and costs of the condition for 11 countries. The researchers summarised and pooled the individual healthcare systems data for more than 600,000 people with diagnosed heart failure in the participating countries between 2018 and 2020. The prevalence of heart failure among adults was 2% when applying the broad definition, and 1% when applying the strict definition, across all 11 countries and more than 32 million people. Risks of annual hospital admission were highest for those with heart failure and chronic kidney disease (19%) and the annual death rate was 13%. The costs of hospital care were highest for those with both heart and kidney disease, and higher than those stemming from coronary artery disease and stroke. These findings indicate the need for urgent action.
Today: December 4, 2023